medicinal cannabis
Restricted representations
The TGA has handed down more than $23K in fines relating to unlawful advertising of medicinal cannabis to treat cancer, and of homeopathy for COVID-19 The Therapeutic Goods Administration made …
Research Roundup
Debbie Rigby takes a look at the latest in research news Integration of non-dispensing pharmacists into primary healthcare services This umbrella review and narrative synthesis suggest that the integration of …
Research Roundup
Debbie Rigby rounds up the latest in research news Inhaled budesonide for COVID-19 in people at higher risk of adverse outcomes in the community Interim analyses from the PRINCIPLE trial …
Medicinal cannabis warning
With certain medicinal cannabis products now S3 but not yet available in pharmacy, the TGA is warning about the risks of buying online On Monday the Therapeutic Goods Administration warned …
Research Roundup
Debbie Rigby rounds up the latest in research news Multiple short courses of corticosteroids in children Short courses of oral steroids (less than two weeks) in children are very unlikely …
Clinical tips: Medical Cannabis
Ben Basger takes a look at some issues around medicinal cannabis, including the fact that data is still very much emerging Speaking to our Professor of Pain Management and Palliative …
The week in review
There’s been a lot happening in pharmacy this week, with COVID-19 vaccine and scheduling news coming to the fore Pharmacist and ALP MP for Dobell Emma McBride called in Parliament …
OTC cannabis at CWH
A medicinal cannabis company has entered an exclusive deal with Chemist Warehouse, as low-dose cannabidiol goes S3 Cannatrek Limited made the announcement on Wednesday, saying that it will supply the …
Medicinal cannabis: the current state of play
Despite the accumulating body of scientific knowledge about, and the growing demand for access to products derived from medicinal cannabis, there is still an absence of the clinical trial data …
Some CBD meds downscheduled
The TGA has announced a final decision to downschedule certain low dose cannabidiol (CBD) preparations These preparations are set to be downscheduled from Schedule 4 (Prescription Medicine) to Schedule 3 …
World news wrapup: 10 December 2020
Insurance plan means pharmacy owner can’t use his own pharmacy; technician struck off after falsely claiming to be disaster victim; NZ pharmacies under scrutiny over cannabis prices London, England: A …
‘We would not want the pharmacy profession being set up to fail.’
Stakeholders have welcomed an interim TGA decision to downschedule low-dose cannabidiol to S3 – but the peak pharmacist body warns that evidence and therapeutic purpose are key The TGA has …